Form 4 for IMVT Immunovant, Inc.
Accepted 2026-04-09 16:17:27 ET · period of report 2026-04-07 · accession 0001764013-26-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-09 16:17 | 2026-04-07 | IMVT | Van Tuyl Christopher | CLO | A - Grant | $0.00 | +41.3K | 188.4K | +28% | $0 |
| D | 2026-04-09 16:17 | 2026-04-07 | IMVT | Van Tuyl Christopher | CLO | A - Grant | $0.00 | +59.8K | 59.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-07 | A | A | 41,343 | $0.00 | 188,396 | D | — | — | (F1) These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date. |
| 2 | Derivative | Stock Option (right to buy) | 2026-04-07 | A | A | 59,820 | $0.00 | 59,820 | D | $24.61 · — to 2036-04-07 | 59,820 Common Stock | (F2) These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date. |